Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about alpha_synuclein_aggregation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
A mechanism referenced in 4 knowledge graph relationships. Key connections: causes dopaminergic_neuron_death (mechanism); glucosylceramide_accumulation (mechanism) promotes; inhibits GCase (protein).
No AI portrait yet
| Name | alpha_synuclein_aggregation |
| Key Genes/Proteins | ALOX15, APOE4, GCase, HSP70 |
| Related Diseases | alzheimers, neurodegeneration, oxidative_stress |
| Related Pathways | glymphatic_clearance, lactate production, lysosomal_function, microglial_activation, mitochondrial_dysfunction |
flowchart TD
N0["Alpha-Synuclein Aggregation"]
N1["Parkinson's Disease"]
N0 -->|"causes"| N1
N2["Mitochondrial Depolarization"]
N0 -->|"causes"| N2
N3["Dopaminergic Neurons"]
N0 -->|"causes"| N3
N4["ATP Production"]
N0 -.->|"downregulates"| N4
N5["Autophagy-Lysosomal Pathway"]
N0 -->|"involved in"| N5
N6["Short-Chain Fatty Acids"]
N6 -->|"modulates"| N0
N7["Piperine"]
N7 -.->|"inhibits"| N0
N8["D-520"]
N8 -.->|"suppresses"| N0
N9["Mitochondrial Fragmentation"]
N0 -->|"causes"| N9
N10["Neurodegeneration"]
N0 -->|"causes"| N10
N11["CNS Inflammation"]
N0 -->|"causes"| N11
N12["BMAL1"]
N12 -.->|"inhibits"| N0
N13["ceftriaxone"]
N13 -.->|"inhibits"| N0
N14["SNCA"]
N14 -->|"regulates"| N0
N15["Polyamines"]
N15 -->|"modulates"| N0
classDef gene fill:#1a3a2a,stroke:#4caf50,color:#e0e0e0
classDef protein fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
classDef disease fill:#3a1a1a,stroke:#ef5350,color:#e0e0e0
classDef pathway fill:#2a1a3a,stroke:#ce93d8,color:#e0e0e0
classDef mechanism fill:#2a2a1a,stroke:#ffd54f,color:#e0e0e0
classDef therapeutic fill:#1a2a2a,stroke:#26a69a,color:#e0e0e0
class N1 disease
class N5 pathway
class N12 gene
class N14 gene| Target | Relation | Type | Str |
|---|---|---|---|
| mitochondrial_dysfunction | correlates_with | mechanism | 0.90 |
| neurodegeneration | causes | disease | 0.90 |
| Parkinson's disease | causes | unknown | 0.90 |
| Parkinson's disease | contributes_to | unknown | 0.90 |
| ALOX15 | increases_risk | gene | 0.85 |
| alzheimers | associated_with | disease | 0.85 |
| Parkinson's disease | associated_with | unknown | 0.82 |
| glymphatic_clearance | associated_with | mechanism | 0.80 |
| neuroinflammation | contributes_to | mechanism | 0.80 |
| neuroinflammation | causes | mechanism | 0.80 |
| microglial_activation | activates | mechanism | 0.75 |
| microglial_activation | contributes_to | mechanism | 0.75 |
| mitochondrial_dysfunction | associated_with | mechanism | 0.75 |
| neurodegeneration | contributes_to | disease | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GCase | interacts_with | protein | 0.95 |
| Parkinson's disease | associated_with | unknown | 0.95 |
| GCase | involved_in | protein | 0.95 |
| GCase | contributes_to | protein | 0.95 |
| GCase | inhibits | protein | 0.90 |
| ambroxol | inhibits | drug | 0.90 |
| ALOX15 | associated_with | gene | 0.90 |
| HSP70 | degrades | protein | 0.85 |
| GCase | associated_with | protein | 0.85 |
| lactate production | promotes | mechanism | 0.85 |
| glymphatic_clearance | mediates | mechanism | 0.80 |
| HSP70 | inhibits | protein | 0.80 |
| mitochondrial_dysfunction | contributes_to | mechanism | 0.80 |
| glymphatic_clearance | modulates | mechanism | 0.80 |
| lysosomal_function | modulates | mechanism | 0.80 |
| glymphatic_clearance | inhibits | mechanism | 0.75 |
| oxidative_stress | contributes_to | phenotype | 0.75 |
| TREM2_protein | associated_with | protein | 0.75 |
| GCase | modulates | protein | 0.75 |
| neuroinflammation | associated_with | mechanism | 0.75 |
| APOE4 | contributes_to | protein | 0.70 |
| HSP70 | modulates | protein | 0.70 |
| alzheimers | associated_with | disease | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Glucosylceramide accumulation nucleates alpha-synuclein aggr | 0.000 | Parkinson's disease | GBA-Synuclein Loop Therapeutics for PD |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.605
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.571
neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.778
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.60 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 1.00 · 2026-04-26
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
closed · Rounds: 4 · Score: 0.84 · 2026-04-16
Hypotheses and analyses mentioning alpha_synuclein_aggregation in their description or question text
No additional research found